Comparing Brixadi vs Sublocade
| Brixadi (buprenorphine) | Sublocade (buprenorphine) |
|
|---|
| Brixadi (buprenorphine) | Sublocade (buprenorphine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Opiate Dependence - Maintenance, Opioid Use Disorder. Brixadi may also be used for purposes not listed in this medication guide. |
Prescription only
Sublocade is a once-monthly injection that may be used to treat adults with opioid use disorder and is administered subcutaneously (under the skin) into the stomach (abdomen), thigh, buttock, or... View more |
Related suggestions Opioid Use Disorder
Opiate Dependence - Maintenance
|
|||||||||||||||
| More about Brixadi (buprenorphine) | More about Sublocade (buprenorphine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Brixadi has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Sublocade has an average rating of 7.9 out of 10 from a total of 308 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Brixadi side effects |
View all Sublocade side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
|
None |
None |
||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Brixadi prices |
View all Sublocade prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other buprenorphine brands include: Belbuca, Buprenex, Butrans, Sublocade | Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
48 hours |
48 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 729 drugs are known to interact with Brixadi:
|
A total of 729 drugs are known to interact with Sublocade:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 23, 2023 |
November 30, 2017 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.